Next-Generation Psychedelic Drug Development

Lindsay P. Cameron, Matthew W. Johnson, Kevin S. Murnane, Mark M. Rasenick, Charles D. Nichols

Open source

DOI: 10.1021/acschemneuro.6c00492
Published: 2026-09-14
Container: ACS Chemical Neuroscience
Publisher: American Chemical Society (ACS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acschemneuro.6c00492,
  title = {Next-Generation Psychedelic Drug Development},
  author = {Lindsay P. Cameron and Matthew W. Johnson and Kevin S. Murnane and Mark M. Rasenick and Charles D. Nichols},
  year = {2026},
  journal = {ACS Chemical Neuroscience},
  doi = {10.1021/acschemneuro.6c00492},
  url = {https://doi.org/10.1021/acschemneuro.6c00492}
}

RIS

TY  - JOUR
TI  - Next-Generation Psychedelic Drug Development
AU  - Lindsay P. Cameron
AU  - Matthew W. Johnson
AU  - Kevin S. Murnane
AU  - Mark M. Rasenick
AU  - Charles D. Nichols
PY  - 2026
JO  - ACS Chemical Neuroscience
DO  - 10.1021/acschemneuro.6c00492
UR  - https://doi.org/10.1021/acschemneuro.6c00492
ER  -

APA

Cameron, L. P., Johnson, M. W., Murnane, K. S., Rasenick, M. M., & Nichols, C. D. (2026). Next-Generation Psychedelic Drug Development. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.6c00492

Source records

crossref · retrieved 2026-11-05T23:28:39.899Z